Evidence map›Paper›PMID 34585944›Full record

ArticleMicrobiology spectrum2021

Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.

Wataru Hayashi, Katsutoshi Izumi, Satoshi Yoshida, Shino Takizawa, Kanae Sakaguchi, Keita Iyori, Ken-Ichi Minoshima, Shinya Takano, Maki Kitagawa, Yukiko Nagano and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Outbreak of Carbapenem-Resistant High-Risk Clone ST244 ofAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Acquired antibiotic resistance ofAIMS microbiology · 2025
    Review
  5. ThePathogens (Basel, Switzerland) · 2024
    Article
  6. Molecular Epidemiology ofAntibiotics (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Rapid typing ofFrontiers in microbiology · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producingFrontiers in cellular and infection microbiology · 2023
    Article
  13. Antimicrobial resistance and genotyping ofFrontiers in veterinary science · 2023
    Article
  14. Antimicrobial Resistance and Genetic Diversity ofPathogens (Basel, Switzerland) · 2022
    Article
  15. The Intriguing Carbapenemases ofThe Yale journal of biology and medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Wataru HayashiDepartment of Medical Sciences, Shinshu University Graduate School of Medicine, Science and Technology, Nagano, Japan.
Katsutoshi IzumiDepartment of Health and Medical Sciences, Shinshu University Graduate School of Medicine, Nagano, Japan.
Satoshi YoshidaDepartment of Health and Medical Sciences, Shinshu University Graduate School of Medicine, Nagano, Japan.
Shino TakizawaDepartment of Health and Medical Sciences, Shinshu University Graduate School of Medicine, Nagano, Japan.
Kanae SakaguchiDepartment of Health and Medical Sciences, Shinshu University Graduate School of Medicine, Nagano, Japan.
Keita IyoriVDT Co., Ltd., Tokyo, Japan.
Ken-Ichi MinoshimaVDT Co., Ltd., Tokyo, Japan.
Shinya TakanoResearch and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan.
Maki KitagawaResearch and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan.
Yukiko NaganoNagoya University Graduate School of Medicine, Nagoya, Japan.
Noriyuki NaganoDepartment of Medical Sciences, Shinshu University Graduate School of Medicine, Science and Technology, Nagano, Japan.ORCID 0000-0002-3657-8029
Shinshu University · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the current trends in antimicrobial resistance among Pseudomonas aeruginosa clinical isolates of canine and feline origin and the prevalence of their sequence types (STs) and type III secretion system (T3SS) virulotypes, which remains unknown in Japan. A total of 240 nonduplicate clinical isolates of P. aeruginosa from dogs (

Indexed as

AnimalsAnti-Bacterial AgentsBacterial ProteinsCarbapenemsCat DiseasesCatsCiprofloxacinDog DiseasesDogsDrug Resistance, BacterialHospitals, AnimalJapanPseudomonas aeruginosaPseudomonas InfectionsType III Secretion SystemsVirulenceAnti-Bacterial AgentsBacterial ProteinsCarbapenemsCiprofloxacinType III Secretion Systemscompanion animalPseudomonas aeruginosaST235T3SS

Identifiers

PMID34585944
PMCPMC8557929
OpenAlexW3203203996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.